More on TNXP

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+32.3% Growth)
- Ratings (6.0 Score)
- Holders

Upcoming Events

- Earnings (11/9/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Tonix Pharma (NQ:TNXP)
Delayed: 9.65 --0 (-0%)
Prev. Close $9.65  
Open$9.62 
52 Wk High$7.95 
52 Wk Low$0.40 
Day High$9.73 
Day Low$9.57 
P/E N/A  
EPS$-5.33 
Volume64,945 

Friends, Peers and Foes (?): AEMD, CVKD, DYAI, ICU, JAGX (more...)

Sep 22, 2026 07:06 AM Form 8-K Tonix Pharmaceuticals For: Sep 22
Sep 22, 2026 07:03 AM Tonix adds second Medicare payer deal for fibromyalgia drug Tonmya
Sep 22, 2026 07:00 AM Tonix Pharmaceuticals Announces Second Major Managed Medicare Payer Agreement for TONMYA®
Sep 22, 2026 05:06 AM Raymond James Reiterates Strong Buy Rating on Tonix Pharma (TNXP)
Aug 24, 2026 08:00 AM Form 4 Tonix Pharmaceuticals For: Aug 20 Filed by: BAGGER RICHARD H
Aug 18, 2026 04:01 PM Tonix Pharma CEO named interim chief medical officer
Aug 18, 2026 04:00 PM Form 8-K Tonix Pharmaceuticals For: Aug 18
Aug 14, 2026 08:36 AM Form SCHEDULE 13G/A Tonix Pharmaceuticals Filed by: Sirenia Capital Management LP
Aug 13, 2026 09:18 AM Form SCHEDULE 13G Tonix Pharmaceuticals Filed by: AQR CAPITAL MANAGEMENT LLC
Aug 10, 2026 01:46 PM Tonix Pharma (TNXP) PT Raised to $27 at Raymond James
View All Articles

Entities mentioned with TNXP

View All Entities